Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Cancer Treatment Reviews|February 20, 2021
Breast MRI in DCIS size estimation, breast-conserving surgery and oncoplastic breast surgeryAlexander Bartram, Fiona Gilbert, Alastair Thompson, et al.The British Journal of Radiology|September 9, 2020
Improving the image quality of DWI in breast cancer: comparison of multi-shot DWI using multiplexed sensitivity encoding to conventional single-shot echo-planar imaging DWIGabrielle C Baxter, Andrew J Patterson, Ramona Woitek, et al.Scientific Reports|July 3, 2020
Author Correction: Ultra Short Echo Time MRI of Iron-Labelled Mesenchymal Stem Cells in an Ovine Osteochondral Defect ModelJoshua D Kaggie, Hareklea Markides, Martin J Graves, et al.Scientific Reports|May 23, 2020
Ultra Short Echo Time MRI of Iron-Labelled Mesenchymal Stem Cells in an Ovine Osteochondral Defect ModelJoshua D Kaggie, Hareklea Markides, Martin J Graves, et al.NPJ Digital Medicine|March 7, 2026
Performance of breast cancer risk prediction algorithms across mammography systems in the UK screening programmeJoshua Rothwell, Nicholas Payne, Fleur Kilburn-Toppin, et al.European Radiology|April 3, 2025
Improving the diagnostic performance of contrast-enhanced mammography through lesion conspicuity and enhancement quantificationIris Allajbeu, Muzna Nanaa, Roido Manavaki, et al.European Radiology|November 15, 2024
Misdiagnosis in breast imaging: a statement paper from European Society Breast Imaging (EUSOBI)-Part 1: The role of common errors in radiology in missed breast cancer and implications of misdiagnosisIsabelle Thomassin-Naggara, Fleur Kilburn-Toppin, Alexandra Athanasiou, et al.European Radiology|November 15, 2024
Misdiagnosis in breast imaging: a statement paper from European Society Breast Imaging (EUSOBI)-Part 2: Main causes of errors in breast imaging and recommendations from European Society of Breast Imaging to limit misdiagnosisIsabelle Thomassin-Naggara, Alexandra Athanasiou, Fleur Kilburn-Toppin, et al.BMC Cancer|December 17, 2009
APRIL is a novel clinical chemo-resistance biomarker in colorectal adenocarcinoma identified by gene expression profilingRussell D Petty, Leslie M Samuel, Graeme I Murray, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 7, 2023
European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSOIsabel T Rubio, Lynda Wyld, Lorenza Marotti, et al.Pageof 2